Other conferences by IBC »
You are here: Home » Sponsorship


Partnership and Profile Building Opportunities are Now Available

Do you Provide Services/Solutions In…

  • Legal
  • Regulatory
  • Market Access
  • Contract Research
  • Contract Manufacturing
  • Logistics/Supply Chain
  • Drug Discovery Research/Screening

Would you like to raise your visibility in the Domestic Chinese and International R&D Market?

  • take advantage of our branding opportunities via the website, marketing and advertising campaigns, social media platforms and many other options.

Could you benefit from showcasing your products & services before key industry players?

  • achieve this via a high profile speaking slot, chairing a panel debate, participate in a showcase session and many more opportunities.

Are you seeking the lowest cost way of meeting a target audience of decision-makers?

  • If so, we can help you achieve your goals
See Who You Will Meet at This Year’s Event!

Sponsorship Prospectus Post Event Report
Sponsorship Solutions
Can Be Tailored to Your Needs!

To position your company as a market leader at this event, and to explore the range of thought leadership, speaking, branding and marketing opportunities available, please contact

Yvonne Leong
+65 6508 2489

2013 Sponsors and Exhibitors

Bronze Sponsor


Panel Session Sponsors

Past Sponsors & Exhibitors Include

MPI Research - Shanghai Medicilon Inc - Qiming Ventures Partners - Inc Research – PPD - Marken Ltd - MDS Pharma Services - Bio Duro - Microconstants China Inc - Life Technologies - Covance Caps Ltd -Beijing Origene Technology Co Ltd – Genscript -  Xenotech, Llc  - Labpartner (Shanghai) Co., Ltd - Hangzhou Hunter Biotech Co., Ltd - Viva Biotech Ltd - Hec Pharma Co. Ltd - Caesar, Rivise, Bernstein, Cohen & Monitor Group - Molecular Devices Hong Kong Ltd – Perkin Elmer Inc. – Questel - Catalent Pharma Solutions

Sponsors and Exhibitors

Panel Session Sponsors

Sundia is a leading CRO company located in the Zhangjiang Hightech Park of Shanghai, China.  Sundia was founded by a group of veterans of the US biopharmaceutical industry. The founding team has received advanced doctorate degrees or training in US and each has got over 10-years of extensive working and/or management experience in the pharmaceutical & biotech industry.  Sundia has always focused on customers' needs since we believe customer’s success is our success. Sundia has provided "One Stop for All" CRO services for more than 120 companies in US, Europe and Japan to fit the increasing market demands for better and more efficient drug discovery & development process. Our integrated services include custom synthesis, medicinal chemistry, library production, hit generation, lead optimization, process chemistry R & D, API cGMP production, formulation development, PK in vitro & in vivo research & pre-clinical study. Sundia currently has over 190,000 sq. ft office/labs & 14 acres space of API/GMP manufacture facility and has employed around 700 scientists, of whom 20% are Ph.D.'s, 55% MS's, and 25% BS's.

For more information please visit our website, http://www.sundia.com.


Bronze Sponsor

Pharma is entering a transformative business environment that creates an unprecedented focus on organizational decision making and its ties to Return-On-Investment (ROI) and business productivity. This focus has special relevance for R&D functions where decisions are based on the constant expansion of scientific and medical knowledge and can have long term positive business impact. At Elsevier, we enable biomedical R&D by delivering essential information for target finding and validation, molecule design, model validation and clinical trial design. The information we deliver spans peer reviewed published literature, conferences and patents and covers the latest biomedical research and clinical information essential for R&D productivity


Molecular Devices provides one of the widest ranges of bioanalytical systems for life science and drug discovery research available from a single supplier. Our systems are built on proprietary technology platforms that deliver high performance, flexibility, and reliability. Molecular Devices acquired Universal Imaging Corporation in 2002, Axon Instruments in 2004, and Blueshift Technologies in 2008, broadening its portfolio to include electrophysiology products, scanners and analysis software for microarrays, and workstations for cell-based screening using high-resolution imaging. The plate readers contain high efficiency tunable absorbance, fluorescence intensity, luminescence, TRF, FP, FRET, TR-FRET, HTRF detection modes and endpoint, kinetic, spectral & well scanning read types.


Networking Photos


 Register Now
Register Online
+65 6508 2401
+65 6508 2407
Customer Services

Download Prospectus

 Co-located With:

Download New Emerging R&D and Clinical Trial Locations White Paper
  Post Event Report

 Quick Links

 Connect Now
Add to Calendar
Add to Favourites
Register for E-update

Produced By
Panel Sponsors  
Bronze Sponsor


Supported by

Media Partners